In addition, BTN3A1 is expressed in many tumors, such as ovarian cancer, bladder cancer, breast cancer, renal cell carcinoma and pancreatic ductal adenocarcinoma [14–17]. Here, BTN3A1 is linked to urinary bladder carcinoma.